In our retrospective LIHC cohort, there was no marked different between FDX1 expression and clinical information, but the variation trend of FDX1 in gender, family cancer history, and pathologic stage was similar with that in the LIHC cohort (Figure S1). Here, FDX1 is linked to cancer.